Zendal Group
Press
Careers

You are on Vetia’s International website.

Go to Vetia Spain

CUBOLAC Vacuna inactivada frente a la clostridiosis

The packaging image may vary depending on the country in which it is marketed.

Logotipo CZ Vaccines
Manufacturer
CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription

CUBOLAC

Inactivated vaccine against clostridiosis, in an injectable suspension
REQUEST MORE INFO
Target species
Cattle icon
Cattle
Sheep icon
Sheep
Goats icon
Goats
Composition
Active substance
Cl. perfringens Type A α Toxoid ≥0,3 UI*
Cl. perfringens Type C ß toxoid ≥10 UI*
Cl. perfringens Type D e Toxoid ≥5 UI*
Cl. septicum α Toxoid ≥2,5 UI*
Cl. novyi Type B α Toxoid ≥3,5 UI*
Cl. sordellii Toxoid100 % de protección**
Inactivated Cl. chauvoei100 % de protección**

* IU: International units of antitoxin per ml of rabbit serum.

** Protection level in guinea pigs according to Pharm. Eur.


Adjuvant:
Aluminium hydroxide (Al+3)2,8 mg
Indications
For active and passive immunisation against symptomatic anthrax, necrotising infectious hepatitis, malignant oedema and enterotoxemias caused by Cl. chauvoei, Cl. novyi Type B, Cl. septicum, Cl. sordellii and Cl. perfringens Types A, C and D. It also confers immunity against Cl. perfringens Type B due to the combination of the fractions from Type C (β toxin) and Type D (e toxin).
Route of administration
Subcutaneous or intramuscular.
Dosage
Dose:
  • Cattle: 5 ml.
  • Sheep: 2 ml.
  • Goat: 2 ml.
Vaccination schedule:
  • Primary vaccination:
    • 2 doses: With a 6-week interval

  • Revaccination:
    • 1 dose: Every 6 months

*Pregnant female cattle and sheep should be vaccinated 14 days before parturition, and pregnant goats about 60 days before parturition.
Withdrawal period
Zero days.
CUBOLAC Vacuna inactivada frente a la clostridiosis

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
CZ Vaccines S.A.U.
Medicamento sujeto a prescripción veterinaria

CUBOLAC

Inactivated vaccine against clostridiosis, in an injectable suspension
SOLICITE INFORMACIÓN
PREVENTING WITH EXPERTS
Composición por dosis (2 ml)
Active substance
Cl. perfringens Type A α Toxoid ≥0,3 UI*
Cl. perfringens Type C ß toxoid ≥10 UI*
Cl. perfringens Type D e Toxoid ≥5 UI*
Cl. septicum α Toxoid ≥2,5 UI*
Cl. novyi Type B α Toxoid ≥3,5 UI*
Cl. sordellii Toxoid100 % de protección**
Inactivated Cl. chauvoei100 % de protección**

* IU: International units of antitoxin per ml of rabbit serum.

** Protection level in guinea pigs according to Pharm. Eur.


Adjuvant:
Aluminium hydroxide (Al+3)2,8 mg
Indicaciones
For active and passive immunisation against symptomatic anthrax, necrotising infectious hepatitis, malignant oedema and enterotoxemias caused by Cl. chauvoei, Cl. novyi Type B, Cl. septicum, Cl. sordellii and Cl. perfringens Types A, C and D. It also confers immunity against Cl. perfringens Type B due to the combination of the fractions from Type C (β toxin) and Type D (e toxin).
Vía de administración
Subcutaneous or intramuscular.
Posología
Dose:
  • Cattle: 5 ml.
  • Sheep: 2 ml.
  • Goat: 2 ml.
Pauta de vacunación
  • Primary vaccination:
    • 2 doses: With a 6-week interval

  • Revaccination:
    • 1 dose: Every 6 months

*Pregnant female cattle and sheep should be vaccinated 14 days before parturition, and pregnant goats about 60 days before parturition.
Tiempo de espera
Zero days.
Scroll to Top